Pfizer and BioNTech have set the initial price at $19.50 a dose, which comes to $39 per patient (since each vaccine requires a two-dose regimen), in its $1.95 billion contract with the federal government as part of Operation Warp Speed in July. Pfizer and BioNTech, which have developed an mRNA-based vaccine, will receive that amount for the first 100 million doses, pending regulatory approval. Moderna, which has developed a competing mRNA vaccine, received nearly $1 billion from the Biomedical Advanced Research and Development Authority and has a $1.5 billion contract for 100 million doses, bringing its price to around $50 per patient or $25 a dose.
Pfizer and BioNTech have set the initial price at $19.50 a dose, which comes to $39 per patient (since each vaccine requires a two-dose regimen), in its $1.95 billion contract with the federal government as part of Operation Warp Speed in July. Pfizer and BioNTech, which have developed an mRNA-based vaccine, will receive that amount for the first 100 million doses, pending regulatory approval. Moderna, which has developed a competing mRNA vaccine, received nearly $1 billion from the Biomedical Advanced Research and Development Authority and has a $1.5 billion contract for 100 million doses, bringing its price to around $50 per patient or $25 a dose.
(post is archived)